Advanced Health Intelligence Secures Funding via Convertible Loan Facility
South Perth, Australia--(Newsfile Corp. - September 12, 2023) - Advanced Health Intelligence Ltd (ASX: AHI) (NASDAQ: AHI) ("AHI" or the...
Financial
Edifecs Appoints Dr. Summerpal Kahlon, M.D., as Chief Medical Officer
Health technology leader and seasoned clinician brings deep experience in value-based payments and health innovationBELLEVUE, Wash.--(BUSINESS WIRE)--Edifecs, Inc., a global...
SomaLogic researchers identify key proteins to aid in early detection of lung, colon and breast cancer and ovarian tumors
SomaLogic’s SomaScan® platform was used to target 15 markers shared among all cancer types.BOULDER, Colo., Sept. 12, 2023 (GLOBE NEWSWIRE)...
CorVel Announces First Generative AI Module
New Capabilities to Interpret Content Will Improve Speed and Accuracy of Evaluating Medical RecordsFORT WORTH, Texas, Sept. 12, 2023 (GLOBE...
Avertix to Present at Two Upcoming Investor Conferences in September 2023
EATONTOWN, N.J., Sept. 11, 2023 (GLOBE NEWSWIRE) -- Avertix Medical, Inc. (“Avertix” or the “Company”), a company focused on improving...
Advanced Health Intelligence Ltd Signs Collaboration Agreement with Bin Farhood International Business Management Group L.L.C
Highlights AHI enters collaboration with His Excellency Dr Obaid Alketbi.Bin Farhood Group Founders have worked with and within the Government...
Driven Data and HeroX Tapped to Enhance Crowdsourcing Challenge for Early Detection of Alzheimer’s and Related Dementias
Goal is more accurate tests, tools, and methodologies; $650K total prize purse BOULDER, Colo., Sept. 7, 2023 /PRNewswire/ -- DrivenData, the...
SOPHiA GENETICS Announces the IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) is Live on the SOPHiA DDM™ Platform
With the help of the SOPHiA DDM™ Platform, IRST has introduced a new diagnostic kit that will support data-driven treatment...
New Analysis Shows Reduction in Annual Patient Costs and Medical Claims with Medisafe
According to the analysis, MS and epilepsy patients experienced reduced annual healthcare costs of $6,280 and $4,600, respectively, on average...
GE HealthCare and Mass General Brigham Collaborate on an AI Algorithm to Predict Missed Care Opportunities
In preliminary tests, the AI-enabled algorithm was able to correctly predict the missed care opportunity (MCO) at rates of up...
Predictmedix AI’s 2023 Breakthroughs: Pioneering Healthcare Innovation and Global Expansion
TORONTO, ON / ACCESSWIRE / September 6, 2023 / Predictmedix AI Inc. (CSE:PMED)(OTCQB:PMEDF)(FRA:3QP) (the "Company" or "Predictmedix") today provided an...
Cognetivity Neurosciences’ AI Powered CognICA Platform Shortlisted for Major Industry Award
CognICA Shortlisted for Most Innovative AI Product in Healthcare Award at CogX FestivalVancouver, British Columbia--(Newsfile Corp. - September 5, 2023)...
Cerevance Announces Presentation at the 22nd Society of Chemical Industry / Royal Society of Chemistry Medicinal Chemistry Symposium
BOSTON, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Cerevance, a private, clinical-stage drug discovery and development company focused on advancing novel,...
Cognetivity Neurosciences Announces Publication of Peer-Reviewed Article Showing Effectiveness of its AI Powered CognICA Technology in Detecting Early-Stage Alzheimer’s Disease
Cognetivity's Landmark ADePT Study, Funded by the UK Innovation Agency and Published in Leading Neuroscience Journal Demonstrates Unprecedented Sensitivity in...
Nova Mentis Announces Participant Screening Underway in Canada’s First Psilocybin Clinical Trial for Fragile X Syndrome
Vancouver, British Columbia--(Newsfile Corp. - August 30, 2023) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF)...
Peregrine Health Services Adds Nationally Known Experts to Its Emergency Department, Trauma Center Consulting Team
Dr. Douglas Slakey and Michael S. Brown join the firm as strategic advisors to help emergency departments and trauma centers...
Fierce Biotech Names Cerevance a “Fierce 15” Biotech Company of 2023
BOSTON, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Cerevance, a private, clinical-stage drug discovery and development company focused on advancing novel,...
Superluminal Medicines Launches with $33 Million Seed Round to Fuel its Drug Discovery Engine and Pipeline of Small Molecule Therapeutics
Financing led by RA Capital Management with participation from Insight Partners, NVIDIA, and Gaingels Superluminal combines deep biology and chemistry...
IIOT-OXYS, Inc. Reports 2023 Form 10-Q Second Quarter Results and Upcoming Investor Conference Call
CAMBRIDGE, MA / ACCESSWIRE / August 25, 2023 / IIOT-OXYS, Inc. (OTC PINK:ITOX) ("Oxys" or the "Company") announced its financial...
Suki Becomes First AI-Powered Healthcare Solution with Enhanced Ambient Integration Across Multiple EHR Systems
Clinicians benefit from a more robust and streamlined documentation experience on CernerREDWOOD CITY, Calif.--(BUSINESS WIRE)--Building upon the introduction of bi-directional...